Correlation Between Solid Biosciences and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Solid Biosciences and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Solid Biosciences and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Solid Biosciences LLC and ANI Pharmaceuticals, you can compare the effects of market volatilities on Solid Biosciences and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Solid Biosciences with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Solid Biosciences and ANI Pharmaceuticals.
Diversification Opportunities for Solid Biosciences and ANI Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Solid and ANI is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Solid Biosciences LLC and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Solid Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Solid Biosciences LLC are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Solid Biosciences i.e., Solid Biosciences and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Solid Biosciences and ANI Pharmaceuticals
Given the investment horizon of 90 days Solid Biosciences LLC is expected to generate 3.15 times more return on investment than ANI Pharmaceuticals. However, Solid Biosciences is 3.15 times more volatile than ANI Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 365.00 in Solid Biosciences LLC on May 1, 2025 and sell it today you would earn a total of 342.00 from holding Solid Biosciences LLC or generate 93.7% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Solid Biosciences LLC vs. ANI Pharmaceuticals
Performance |
Timeline |
Solid Biosciences LLC |
ANI Pharmaceuticals |
Solid Biosciences and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Solid Biosciences and ANI Pharmaceuticals
The main advantage of trading using opposite Solid Biosciences and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Solid Biosciences position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.Solid Biosciences vs. AN2 Therapeutics | Solid Biosciences vs. 4D Molecular Therapeutics | Solid Biosciences vs. Monte Rosa Therapeutics | Solid Biosciences vs. Passage Bio |
ANI Pharmaceuticals vs. Collegium Pharmaceutical | ANI Pharmaceuticals vs. Amphastar P | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Evolus Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |